Trials / Withdrawn
WithdrawnNCT03428854
Adenomyosis: Genomic Mechanisms and Biological Response
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- University of Texas Southwestern Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years – 60 Years
- Healthy volunteers
- —
Summary
Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.
Detailed description
Examination of genomic and biologic responses to LNG-IUS in patients with adenomyosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LNG-IUS | Levnorgestrel containing IUD |
Timeline
- Start date
- 2020-12-01
- Primary completion
- 2022-10-01
- Completion
- 2022-10-01
- First posted
- 2018-02-12
- Last updated
- 2021-02-02
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03428854. Inclusion in this directory is not an endorsement.